Trials / Unknown
UnknownNCT02929615
Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Peking University · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to research the standard and individualized treatment model for relapse and refractory lymphatic system malignant tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hematopoietic stem cell transplantation |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2017-12-01
- Completion
- 2018-03-01
- First posted
- 2016-10-11
- Last updated
- 2016-10-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02929615. Inclusion in this directory is not an endorsement.